title: Cyclosporin for atopic dermatitis in children.
abstract: This paper details a UK consensus conference held in London in April 2000 to establish guidelines for the use of cyclosporin A for atopic dermatitis in children. It should be reserved for the severest refractory atopic dermatitis. In view of its potential toxicity, careful monitoring is mandatory, in particular blood pressure and renal function.
authors.affiliation: Department of Paediatric Dermatology, Great Ormond Street Hospital for Children, London, UK.
authors.forename: J I
authors.initials: JI
authors.lastname: Harper
authors.forename: J
authors.initials: J
authors.lastname: Berth-Jones
authors.forename: R D
authors.initials: RD
authors.lastname: Camp
authors.forename: M J
authors.initials: MJ
authors.lastname: Dillon
authors.forename: A Y
authors.initials: AY
authors.lastname: Finlay
authors.forename: C A
authors.initials: CA
authors.lastname: Holden
authors.forename: D
authors.initials: D
authors.lastname: O'Sullivan
authors.forename: P A
authors.initials: PA
authors.lastname: Veys
mesh_terms: D002648:Child; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016903:Drug Monitoring; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine